Navigation Links
Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
Date:11/15/2011

ORLANDO, Fla., Nov. 15, 2011 /PRNewswire/ -- Final results were presented today from the AIM-HIGH study, a National Heart, Lung and Blood Institute (NHLBI) study. The study was designed to test whether raising HDL "good" cholesterol by adding Niaspan to simvastatin would provide an additional 25 percent reduction in cardiovascular outcomes in patients with established cardiovascular disease and well-controlled LDL "bad" cholesterol levels. The study was stopped early following an interim analysis in May and found that combination therapy did not result in an additional reduction in cardiovascular events beyond treatment with simvastatin in this patient population with well-controlled LDL cholesterol and non-HDL-cholesterol (a measure of all plaque causing particles).  In response, Abbott (NYSE: ABT) issued the following statement:

The AIM-HIGH study answered an important question about the benefits of additional lipid treatment for the specific type of patients enrolled in the study – those with stable established cardiovascular disease whose lipids were well-controlled at or near primary and secondary lipid goals at the start of the study. Current treatment guidelines would not have recommended that these patients receive additional lipid therapy.

According to the National Cholesterol Education Program (NCEP) guidelines, LDL cholesterol is the primary target of lipid therapy.  For patients at high cardiovascular risk, such as those enrolled in the AIM-HIGH study, guidelines recommend an optional LDL goal of 70 mg/dL or less.  Additionally, non-HDL cholesterol of 100 mg/dL or less is the secondary goal of lipid treatment for high-risk patients when triglycerides are elevated (greater than 200 mg/dL) and after LDL goal is reached.  Ninety-four percent of patients in the AIM-HIGH study were already taking statins, with most of this group taking
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
2. PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition
3. Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott
4. Experts Report that Abbotts New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense
5. Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees
6. Abbotts Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
7. Abbott Honored With Asian CSR Award for Leadership in Science Education
8. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
9. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
10. Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
11. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft ... Company,s Phase 2 clinical trial.  This open-label study will ... GPX-150 (an investigational medication), in approximately 30 adults as ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 ...
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
(Date:12/26/2014)... said that nothing makes a lady feel more feminine than ... shows its new selection of navy cocktail dresses , ... navy cocktail gowns are the cornerstones of the site’s cocktail ... dresses in bright neon colors can be dressed up or ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... 11, 2007 Physicians at UT Southwestern Medical Center are the ... small radioactive pellet, or seed, is implanted into a mass or ... surgical removal. , During the procedure, a radiologist uses a needle ... grain of rice, into the mass. Once lodged, surgeons use a ...
... Oct. 11, 2007 Dr. Beth Levine, professor ... division of infectious diseases at UT Southwestern Medical Center, ... today. , Dr. Levine is one of 15 new ... a philanthropic organization that promotes biomedical research. Her appointment ...
... 1999 Equity ... Incentive Plan, ... leading provider of state-of-the-art diagnostic and,digital imaging systems directed towards women,s ... that,Hologic stockholders vote "FOR" the Company,s proposed merger with Cytyc,Corporation (Nasdaq: ...
... Just released trial data show high acceptance of interactive ... system, two-thirds of patients prefer automated system, ... a developer,of advanced interactive voice response (IVR) solutions, today ... (IVRS) optimized,for use in the healthcare environment. CallAssure uses ...
... Step-by-Step Process and Provides Sample Appeal,Letter, WASHINGTON, Oct. ... peace of mind that they will have,access to the ... the medicine that,s prescribed by the doctor isn,t always,covered. ... need,to know what they can do about it., ...
... Quality of Health Care, PITTSBURGH, Oct. 11 ... select hospitals in Western Pennsylvania as part of ... line- associated bloodstream infections. Central lines are ... nutrition to critically ill patients through vessels that ...
Cached Medicine News:Health News:New 'seed' therapy helps pinpoint breast tumors with more accuracy 2Health News:UT Southwestern researcher named Howard Hughes Medical Institute investigator 2Health News:UT Southwestern researcher named Howard Hughes Medical Institute investigator 3Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 2Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 3Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 4Health News:Vocantas CallAssure provides hospitals with automated solution for post-discharge patient follow-up 2Health News:Vocantas CallAssure provides hospitals with automated solution for post-discharge patient follow-up 3Health News:New Resource Explains What Seniors Can Do if Medicare Denies Coverage of Their Medicines 2Health News:Highmark's Hospital Pay-for-Performance Program Demonstrates Impressive Results 2Health News:Highmark's Hospital Pay-for-Performance Program Demonstrates Impressive Results 3
Sony DSR-20MD is the right choice If you need digital recording capability. It accepts both s-video and composite inputs....
The VISERA Multi-Specialty Digital Imaging Platform is the world's first integrated system of digital rigid, deflectable tip and flexible videoscopes for use in operating room endosurgery as well as ...
... for clinical image management. Mediscan is ... management system derived from extensive experience ... to capture, organize, and distribute high ... with minimum effort. Can be connected ...
... probes feature response times in ... real-time monitoring of physiological events. ... measurements of pO2, blood perfusion ... from the same tissue site ...
Medicine Products: